Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin.
27 August 2017 (15:45 - 16:15)
Organised by:
About the speakers
University of Texas Southwestern Medical Center, Dallas (United States of America)
University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
Access the full session
The Event
ESC Congress 2017
27 August 2017
15:45 CET
